Rosaria Cammarota
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Oncology top 10%
- Peptidase Inhibition and Analysis 1
-
- Corneal Surgery and Treatments 1
-
- Inflammatory mediators and NSAID effects 2
-
- Carbon Nanotubes in Composites 1
-
- Enzyme function and inhibition 1
-
- Immune Response and Inflammation 1
- Immunotherapy and Immune Responses 1
- Co-authors
- Adriana AlbiniDouglas M. NoonanGiuseppina PennesiFrancesco DonatelliSilvio De FloraMassimo BarberisFausto SessaEugênio Bucci
- Journals
- Molecular Cancer Therapeutics (1 paper)Journal of Translational Medicine (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Rosaria Cammarota
8 papers receiving 929 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cardiology and Cardiovascular Medicine 427
- Oncology 339
- Cancer Research 102
- Radiology, Nuclear Medicine and Imaging 108
- Toxicology 16
Countries citing papers authored by Rosaria Cammarota
This map shows the geographic impact of Rosaria Cammarota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosaria Cammarota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosaria Cammarota more than expected).
Fields of papers citing papers by Rosaria Cammarota
This network shows the impact of papers produced by Rosaria Cammarota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosaria Cammarota. The network helps show where Rosaria Cammarota may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rosaria Cammarota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 37 | |
| 2 | 2010 | 125 | |
| 3 | 2009 | 65 | |
| 4 | Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Preventionbreakdown → | 2009 | 593 |
| 5 | 2008 | 43 | |
| 6 | 2008 | 53 | |
| 7 | 2007 | 5 | |
| 8 | 2007 | 48 |
About Rosaria Cammarota
Rosaria Cammarota is a scholar working on Immunology and Allergy, Cancer Research, Pharmacology, Ophthalmology and Oncology, having authored 8 papers that have together received 969 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Inflammatory mediators and NSAID effects (2 papers), Corneal Surgery and Treatments (1 paper), Carbon Nanotubes in Composites (1 paper), Peptidase Inhibition and Analysis (1 paper), Enzyme function and inhibition (1 paper), Immune Response and Inflammation (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (427 citations), Oncology (339 citations), Cancer Research (102 citations), Radiology, Nuclear Medicine and Imaging (108 citations) and Toxicology (16 citations). Rosaria Cammarota has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Adriana Albini, Douglas M. Noonan, Giuseppina Pennesi, Francesco Donatelli, Silvio De Flora, Massimo Barberis, Fausto Sessa, Eugênio Bucci, Nicola Vannini and Michael B. Sporn. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Translational Medicine, JNCI Journal of the National Cancer Institute, Recent results in cancer research and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.